nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
|
Vervloet, Marc G |
|
2014 |
2 |
5 |
p. 427-436 10 p. |
artikel |
2 |
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study
|
Di Dalmazi, Guido |
|
2014 |
2 |
5 |
p. 396-405 10 p. |
artikel |
3 |
Correction for Lancet Diabetes Endocrinol 2014; published online April 8
|
|
|
2014 |
2 |
5 |
p. e12- 1 p. |
artikel |
4 |
Correction for Lancet Diabetes Endocrinol 2014; published online March 25
|
|
|
2014 |
2 |
5 |
p. e12- 1 p. |
artikel |
5 |
Definition and management of radioactive iodine-refractory differentiated thyroid cancer
|
Schlumberger, Martin |
|
2014 |
2 |
5 |
p. 356-358 3 p. |
artikel |
6 |
Dreaming of normoglycaemia with fewer diet restrictions
|
Ruggenenti, Piero |
|
2014 |
2 |
5 |
p. 350-351 2 p. |
artikel |
7 |
Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial
|
Kwakernaak, Arjan J |
|
2014 |
2 |
5 |
p. 385-395 11 p. |
artikel |
8 |
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
|
Barnett, Anthony H |
|
2014 |
2 |
5 |
p. 369-384 16 p. |
artikel |
9 |
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
|
de Vries, Aiko P J |
|
2014 |
2 |
5 |
p. 417-426 10 p. |
artikel |
10 |
Giovanni Strippoli: finding the pleasures in nephrology
|
Burki, Talha Khan |
|
2014 |
2 |
5 |
p. 367- 1 p. |
artikel |
11 |
How should patients with adrenal incidentalomas be followed up?
|
Pivonello, Rosario |
|
2014 |
2 |
5 |
p. 352-354 3 p. |
artikel |
12 |
How to create yourself
|
Cantor, Abi |
|
2014 |
2 |
5 |
p. 368- 1 p. |
artikel |
13 |
Implantable insulin pumps: an effective option with restricted dissemination
|
Spaan, Nienke A |
|
2014 |
2 |
5 |
p. 358-360 3 p. |
artikel |
14 |
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
|
Stefan, Norbert |
|
2014 |
2 |
5 |
p. 406-416 11 p. |
artikel |
15 |
Kidney failure: are we failing?
|
The Lancet Diabetes & Endocrinology, |
|
2014 |
2 |
5 |
p. 349- 1 p. |
artikel |
16 |
Research in brief
|
Kang, Seema |
|
2014 |
2 |
5 |
p. 366- 1 p. |
artikel |
17 |
Salt, hypertension, and proteinuria in diabetic nephropathy
|
Weir, Matthew R |
|
2014 |
2 |
5 |
p. 351-352 2 p. |
artikel |
18 |
Subclinical Cushing's syndrome and cardiovascular disease
|
Anagnostis, Panagiotis |
|
2014 |
2 |
5 |
p. 361- 1 p. |
artikel |
19 |
Targeting non-alcoholic fatty liver disease through 11-βHSD1 inhibition
|
Ratziu, Vlad |
|
2014 |
2 |
5 |
p. 354-356 3 p. |
artikel |
20 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Grant, William B |
|
2014 |
2 |
5 |
p. 364- 1 p. |
artikel |
21 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Bischoff-Ferrari, Heike A |
|
2014 |
2 |
5 |
p. 363-364 2 p. |
artikel |
22 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Anagnostis, Panagiotis |
|
2014 |
2 |
5 |
p. 362-363 2 p. |
artikel |
23 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes – Authors' reply
|
Bolland, Mark J |
|
2014 |
2 |
5 |
p. 364-365 2 p. |
artikel |
24 |
Vitamin D, obesity, and risk of diabetes
|
Boucher, Barbara |
|
2014 |
2 |
5 |
p. 361-362 2 p. |
artikel |